U.S. approves first marijuana plant-derived drug
(Reuters) - An epilepsy treatment from GW Pharmaceuticals Plc on Monday secured an approval from the U.S. Food and Drug Administration, becoming the first cannabis-based drug to be approved in the country.
from Reuters: Health News https://reut.rs/2tCidZo
http://bit.ly/2zwRqiM
June 25, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on June 25, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.